miRagen Therapeutics is a biopharmaceutical company discovering and developing innovative microRNA (miRNA)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. The Company leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and high-potential drug candidates for its own pipeline or in conjunction with strategic partners.
Boulder, US
Size (employees)
51 (est)
miRagen Therapeutics was founded in 2007 and is headquartered in Boulder, US
Report incorrect company information

miRagen Therapeutics Office Locations

miRagen Therapeutics has an office in Boulder
Boulder, US (HQ)
6200 Lookout Rd.
Show all (1)
Report incorrect company information

miRagen Therapeutics Financials and Metrics

miRagen Therapeutics Financials

Market capitalization (5-Mar-2018)

143 m
miRagen Therapeutics's current market capitalization is $143 m.
Show all financial metrics
Report incorrect company information